Nectar Lifesciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nectar Lifesciences Ltd. on BSE

Search Inside the pdf :

Nectar Lifesciences Ltd.

12 Jul 2025, 01:54PM

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are furnishing herewith newspaper copy of Publication of notice of 2025-26/01st Extraordinary General Meeting ("EGM") of the Company to be held on Monday, August 04, 2025 and remote e-voting facility provided for the proposed resolutions set forth in the notice of EGM, which have been published in the following newspapers: 1. Business Standard (English-all editions) 2. Desh Sewak (Punjabi)

pdf

Nectar Lifesciences Ltd.

11 Jul 2025

19.88

2.16%

AGM

Nectar Lifesciences Ltd - 532649 - Nectar Lifesciences Limited Has Informed The Exchange Regarding Notice Of …

BSE India

Please find attached herewith notice of 2025-26/01st EGM.

pdf

Nectar Lifesciences Ltd.

09 Jul 2025

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached herewith the copy of newspapers for publication of financial results of the Company for the quarter and financial year ended on March 31, 2025.

pdf

Nectar Lifesciences Ltd.

08 Jul 2025

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - General Updates

BSE India

Board Comments on the fine levied by the Exchanges (BSE and NSE)

pdf

Nectar Lifesciences Ltd.

08 Jul 2025

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release - Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ?1,270 Crores

pdf

Nectar Lifesciences Ltd.

07 Jul 2025

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - 1. Slump Sale Of Business; And 2. Sale Of Assets

BSE India

Please find attacherewith letter w.r.t.: 1. Transfer of the active pharmaceutical ingredients and formulations Business on a 'slump sale' basis; 2. Sale, transfer and delivery of Menthol Assets.

pdf

Nectar Lifesciences Ltd.

07 Jul 2025

19.88

2.16%

Result

Nectar Lifesciences Ltd - 532649 - Financial Results For The Year 2024-25

BSE India

Financial Results for the Year 2024-25

pdf

	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	430.77	359.85	-	-
Operating Profit Qtr	-154.30	39.80	-	-
Net Profit Qtr	-130.09	2.97	-	-
Earning Per Share Adjusted latest Qtr	-5.80	0.13	-	-

* Consolidated data

Detailed Results

Nectar Lifesciences Ltd.

03 Jul 2025

19.88

2.16%

Board Meeting

Nectar Lifesciences Ltd - 532649 - Board Meeting Intimation for Annual Audited Financial Results And Other …

BSE India

Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2024-25, Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto.

pdf

Nectar Lifesciences Ltd.

03 Jul 2025

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find attached herewith the certificate as per captioned regulations.

pdf

Nectar Lifesciences Ltd.

01 Jul 2025

19.88

2.16%

Company Update

Nectar Lifesciences Ltd - 532649 - Disclosure As Per Regulation 30 Of The Securities And Exchange …

BSE India

Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015

pdf

Is Nectar Lifesciences Ltd. worth buying?

162 Votes:

Buy 77.78%

Sell 16.67%

Hold 5.56%

New 52W Low in past week

High volume today

Nectar Lifesciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nectar Lifesciences Ltd. on BSE